mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.008 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.01 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.02 |